Xylem (XYL) Common Equity (2010 - 2026)

Xylem's Common Equity history runs 17 years deep, the most recent figure standing at $11.0 billion for Q1 2026.

• In Q1 2026, Common Equity rose 1.46% year-over-year to $11.0 billion; the TTM figure through Mar 2026 stood at $11.0 billion (up 1.46% YoY), while the FY2025 annual figure was $11.5 billion, up 7.82% from the prior year.
• Common Equity was $11.0 billion for Q1 2026 at Xylem, down from $11.5 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $11.5 billion in Q4 2025 to a low of $3.2 billion in Q2 2022.
• Historically, Common Equity has averaged $8.5 billion across 5 years, with a median of $10.2 billion in 2024.
• The sharpest annual moves came in 2023 and 2026: Common Equity surged 209.4% in 2023, then grew 1.46% in 2026.
• A 5-year view of Common Equity shows it stood at $3.5 billion in 2022, then soared by 190.49% to $10.2 billion in 2023, then grew by 4.63% to $10.6 billion in 2024, then rose by 7.82% to $11.5 billion in 2025, then retreated by 4.36% to $11.0 billion in 2026.
• The last three Common Equity figures came in at $11.0 billion (Q1 2026), $11.5 billion (Q4 2025), and $11.2 billion (Q3 2025), per Business Quant data.